Between March and May 2026, the Católica Medical School and Hospital da Luz Lisboa will host the fourth edition of the Global Pharma Executive Course, a flagship training program aimed at leaders in the pharmaceutical industry.
According to João Santos Pereira, Executive Director of the Católica Medical School, “For the Católica Medical School, it is very important to partner with initiatives like this that promote an integrated vision between science, clinical practice, and industry.” He also adds: “The Global Pharma program is already establishing itself as a national reference for pharmaceutical industry executives who wish to strengthen their network and stay up to date with the latest knowledge in the sector.”
Daniel Guedelha, Founder & CEO of GenH, highlights that: “This program was born from the desire to lead, from Portugal, a European program of excellence and to establish the pharmaceutical industry as a strategic pillar of national development. Four editions later, the results speak for themselves.”
Our Executive Director, Ana Rita Constante, emphasizes that: “The Global Pharma Executive Course is a leading program in the sector, creating value for any professional with interest and ambition in the pharmaceutical industry. Regardless of their background – whether in Health, Pharmaceutical Sciences, Management, or Law – this course provides access to current and critical topics, taught by an international team of excellence, preparing participants to address the present and future challenges of the industry.”
👉 Read more about here: https://healthnews.pt/2026/01/05/global-pharma-2026-curso-executivo-reune-lideres-da-industria-farmaceutica-em-portugal/
🔗 More news about this executive course: https://www.netfarma.pt/global-pharma-quarta-edicao-reune-lideres-da-pfizer-msd-jj-sanofi-e-roche/ and https://newsfarma.pt/atualidade/global-pharma-quarta-edicao-reune-lideres-da-pfizer-msd-jj-sanofi-e-roche-em-programa-executivo-de-referencia/